Genome-edited stem cells reveal new hope for obesity treatment without muscle loss

In a study published in Nature Communications, researchers at the Beijing Institute of Stem Cells and Regeneration (BISCRM) and the Institute of Zoology (IOZ) have cracked the code of the notorious FTO gene, reconciling its dual role in obesity and muscle growth. The revelation could improve obesity and diabetes treatments, potentially offering an alternative to popular GLP-1 receptor agonists that may cause undesirable muscle wasting.

Facebook Comments